Circulation:January 6, 2026 Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Primary Outcomes From the STORM-PE Trial

The STORM-PE clinical trial investigated whether using a computer-assisted vacuum thrombectomy device to physically remove blood clots provides better outcomes for high-risk pulmonary embolism patients than standard medication alone. By comparing these two treatments, researchers discovered that the mechanical procedure was significantly more effective at reducing heart strain and normalizing vital signs within the first two days of care. While the physical intervention more rapidly restored the balance between heart chambers, it maintained a safety profile comparable to anticoagulation therapy, showing no significant increase in major complications. Ultimately, this study suggests that combining advanced clot-retrieval technology with traditional medicine offers a superior pathway for stabilizing patients facing life-threatening lung obstructions.